文章名稱(chēng)引用次數(shù)

• Chemsex and new HIV diagnosis in gay, bisexual and other men who have sex with men attending sexual health clinics18
• Two-drug vs. three-drug combinations for HIV-1: Do we have enough data to make the switch?9
• Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion8
• Reduced exposure to darunavir and cobicistat in HIV-1-infected pregnant women receiving a darunavir/cobicistat-based regimen7
• De-simplifying single-tablet antiretroviral treatments: uptake, risks and cost savings6
• HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy6
• BCN Checkpoint: same-day confirmation of reactive HIV rapid test with Point Of Care HIV-RNA accelerates linkage to care and reduces anxiety5
• Planning HIV therapy to prevent future comorbidities: patient years for tenofovir alafenamide5
• The world-wide incidence of Kaposi's sarcoma in the HIV/AIDS era5
• Evolution of major non-HIV-related comorbidities in HIV-infected patients in the Italian Cohort of Individuals, Naive for Antiretrovirals (ICONA) Foundation Study cohort in the period 2004-20144